301111SZSE
🚨 Material Event

Simplified Report on Change of Equity

Yue Wannianqing Co., Ltd.··19 pages

✨ AI Summary

This report details a reduction in shareholding by the controlling shareholder, Guangdong Jinou Health Technology Co., Ltd., and shareholder Guangdong Qiaoyin Real Estate Development Co., Ltd., in Guangdong Wannianqing Pharmaceutical Co., Ltd. The disclosure is made in accordance with the Securities Law and relevant regulations of the Shenzhen Stock Exchange. This filing serves to formally notify the market of the equity change.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Guangdong Wannianqing Pharmaceutical Co., Ltd. Simplified Report on Change of Equity

Listed Company Name: Guangdong Wannianqing Pharmaceutical Co., Ltd. Listing Venue: Shenzhen Stock Exchange Stock Abbreviation: Yue Wannianqing Stock Code: 301111

Information Disclosure Obligor 1: Guangdong Jinou Health Technology Co., Ltd. Domicile/Communication Address: Room A21, South Side, Room 01, 15th Floor, No. 8 Changjiang Road, Longhu District, Shantou City

Information Disclosure Obligor 2: Guangdong Qiaoyin Real Estate Development Co., Ltd. Domicile/Communication Address: Room 313, 3rd Floor, Block C, Nandun Factory, Meiguiyuan, Jinping District, Shantou City

Nature of Equity Change: Reduction of shares Signing Date: June 24, 2026

Declaration of Information Disclosure Obligors

  1. This report is prepared by the information disclosure obligors in accordance with the Company Law, the Securities Law, the Administrative Measures for the Takeover of Listed Companies, the Opinions on the Application of Laws and Regulations to Securities and Futures No. 19—Application Opinions on Articles 13 and 14 of the Administrative Measures for the Takeover of Listed Companies, and the Standards for the Contents and Formats of Information Disclosure by Companies Offering Securities to the Public No. 15—Report on Change of Equity.

  2. The signing of this report by the information disclosure obligors has been duly authorized and approved, and its execution does not violate or conflict with any terms of the articles of association or internal rules of the information disclosure obligors.

  3. In accordance with the relevant provisions of the Securities Law, the Administrative Measures for the Takeover of Listed Companies, and the Standards for the Contents and Formats of Information Disclosure by Companies Offering Securities to the Public No. 15—Report on Change of Equity, this report has fully disclosed the changes in the equity held by the information disclosure obligors in Yue Wannianqing. As of the signing date of this report, except for the information disclosed herein, the information disclosure obligors have not increased or decreased their equity in Yue Wannianqing through any other means.

  4. This change of equity is conducted based on the materials stated in this report. Except for the information disclosed herein, the information disclosure obligors have not entrusted or authorized any entity or individual to provide information not listed in this report or to make any explanations or statements regarding this report.

  5. The information disclosure obligors undertake that this report does not contain any false records, misleading statements, or major omissions, and assume individual and joint legal liability for its authenticity, accuracy, and completeness.

  6. Some data in this report may have rounding differences; investors are advised to take note.

Table of Contents

Section I Definitions: 4 Section II Introduction to Information Disclosure Obligors: 5 Section III Purpose of This Equity Change and Future Shareholding Plan: 7 Section IV Method of This Equity Change: 8 Section V Transactions of Listed Company Shares in the Previous Six Months: 10 Section VI Other Major Matters: 11 Section VII Documents Available for Inspection: 12 Section VIII Declaration of Information Disclosure Obligors: 13 Appendix: Simplified Report on Change of Equity: 15

Section I Definitions

TermDefinition
Listed Company/Company/Yue WannianqingGuangdong Wannianqing Pharmaceutical Co., Ltd.
Report on Change of Equity, This ReportGuangdong Wannianqing Pharmaceutical Co., Ltd. Simplified Report on Change of Equity
Information Disclosure Obligor 1/Controlling Shareholder/Jinou HealthGuangdong Jinou Health Technology Co., Ltd.
Information Disclosure Obligor 2/Shareholder/Qiaoyin Real EstateGuangdong Qiaoyin Real Estate Development Co., Ltd.
This Equity ChangeThe share equity change disclosed by the information disclosure obligors in this report
Company LawCompany Law of the People's Republic of China
Securities LawSecurities Law of the People's Republic of China
CSRCChina Securities Regulatory Commission
SZSE/ExchangeShenzhen Stock Exchange
Yuan, Ten Thousand YuanRMB Yuan, RMB Ten Thousand Yuan

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.